194 related articles for article (PubMed ID: 8852476)
1. Polymerase chain reaction control of antibiotic treatment in dermatoborreliosis.
Muellegger R; Zoechling N; Schluepen EM; Soyer HP; Hoedl S; Kerl ; Volkenandt M
Infection; 1996; 24(1):76-9. PubMed ID: 8852476
[TBL] [Abstract][Full Text] [Related]
2. A two year prospective study to compare culture and polymerase chain reaction amplification for the detection and diagnosis of Lyme borreliosis.
Picken MM; Picken RN; Han D; Cheng Y; Ruzic-Sabljic E; Cimperman J; Maraspin V; Lotric-Furlan S; Strle F
Mol Pathol; 1997 Aug; 50(4):186-93. PubMed ID: 9350301
[TBL] [Abstract][Full Text] [Related]
3. Molecular subtyping of Borrelia burgdorferi in erythema migrans and acrodermatitis chronica atrophicans.
Wienecke R; Zöchling N; Neubert U; Schlüpen EM; Meurer M; Volkenandt M
J Invest Dermatol; 1994 Jul; 103(1):19-22. PubMed ID: 8027576
[TBL] [Abstract][Full Text] [Related]
4. Polymerase chain reaction in diagnosis of Borrelia burgdorferi infections and studies on taxonomic classification.
Lebech AM
APMIS Suppl; 2002; (105):1-40. PubMed ID: 11985118
[TBL] [Abstract][Full Text] [Related]
5. Polymerase chain reaction for detection of Borrelia burgdorferi DNA in skin lesions of early and late Lyme borreliosis.
von Stedingk LV; Olsson I; Hanson HS; Asbrink E; Hovmark A
Eur J Clin Microbiol Infect Dis; 1995 Jan; 14(1):1-5. PubMed ID: 7729446
[TBL] [Abstract][Full Text] [Related]
6. Amplification of Borrelia burgdorferi DNA in skin biopsies from patients with Lyme disease.
Melchers W; Meis J; Rosa P; Claas E; Nohlmans L; Koopman R; Horrevorts A; Galama J
J Clin Microbiol; 1991 Nov; 29(11):2401-6. PubMed ID: 1774243
[TBL] [Abstract][Full Text] [Related]
7. Detection of Borrelia burgdorferi sensu lato in lesional skin of patients with erythema migrans and acrodermatitis chronica atrophicans by ospA-specific PCR.
Moter SE; Hofmann H; Wallich R; Simon MM; Kramer MD
J Clin Microbiol; 1994 Dec; 32(12):2980-8. PubMed ID: 7883886
[TBL] [Abstract][Full Text] [Related]
8. Success and failure in the treatment of acrodermatitis chronica atrophicans.
Aberer E; Breier F; Stanek G; Schmidt B
Infection; 1996; 24(1):85-7. PubMed ID: 8852478
[TBL] [Abstract][Full Text] [Related]
9. Successful amplification of DNA specific for Finnish Borrelia burgdorferi isolates in erythema chronicum migrans but not in circumscribed scleroderma lesions.
Ranki A; Aavik E; Peterson P; Schauman K; Nurmilaakso P
J Invest Dermatol; 1994 Mar; 102(3):339-45. PubMed ID: 8120417
[TBL] [Abstract][Full Text] [Related]
10. Acrodermatitis chronica atrophicans in an 11-year-old girl.
Muellegger RR; Schluepen EM; Millner MM; Soyer HP; Volkenandt M; Kerl H
Br J Dermatol; 1996 Oct; 135(4):609-12. PubMed ID: 8915157
[TBL] [Abstract][Full Text] [Related]
11. Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea.
Buechner SA; Lautenschlager S; Itin P; Bircher A; Erb P
Arch Dermatol; 1995 Jun; 131(6):673-7. PubMed ID: 7778918
[TBL] [Abstract][Full Text] [Related]
12. Isolation of Borrelia burgdorferi sensu lato from a fibrous nodule in a patient with acrodermatitis chronica atrophicans.
Maraspin V; Ruzić-Sabljić E; Strle F
Wien Klin Wochenschr; 2002 Jul; 114(13-14):533-4. PubMed ID: 12422596
[TBL] [Abstract][Full Text] [Related]
13. No evidence for Borrelia burgdorferi-specific DNA in lesions of localized scleroderma.
Wienecke R; Schlüpen EM; Zöchling N; Neubert U; Meurer M; Volkenandt M
J Invest Dermatol; 1995 Jan; 104(1):23-6. PubMed ID: 7798636
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous manifestations of Lyme borreliosis.
Aberer E; Klade H
Infection; 1991; 19(4):284-6. PubMed ID: 1917047
[TBL] [Abstract][Full Text] [Related]
15. Expanding the clinicopathological spectrum of late cutaneous Lyme borreliosis (acrodermatitis chronica atrophicans [ACA]): A prospective study of 20 culture- and/or polymerase chain reaction (PCR)-documented cases.
Lenormand C; Jaulhac B; Debarbieux S; Dupin N; Granel-Brocard F; Adamski H; Barthel C; Cribier B; Lipsker D
J Am Acad Dermatol; 2016 Apr; 74(4):685-92. PubMed ID: 26781226
[TBL] [Abstract][Full Text] [Related]
16. Failure to isolate Borrelia burgdorferi after antimicrobial therapy in culture-documented Lyme borreliosis associated with erythema migrans: report of a prospective study.
Nadelman RB; Nowakowski J; Forseter G; Bittker S; Cooper D; Goldberg N; McKenna D; Wormser GP
Am J Med; 1993 Jun; 94(6):583-8. PubMed ID: 8506882
[TBL] [Abstract][Full Text] [Related]
17. Skin manifestations of lyme borreliosis: diagnosis and management.
Müllegger RR; Glatz M
Am J Clin Dermatol; 2008; 9(6):355-68. PubMed ID: 18973402
[TBL] [Abstract][Full Text] [Related]
18. Course of Borrelia burgdorferi DNA shedding in urine after treatment.
Aberer E; Bergmann AR; Derler AM; Schmidt B
Acta Derm Venereol; 2007; 87(1):39-42. PubMed ID: 17225014
[TBL] [Abstract][Full Text] [Related]
19. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in the urine and breast milk of patients with Lyme borreliosis.
Schmidt BL; Aberer E; Stockenhuber C; Klade H; Breier F; Luger A
Diagn Microbiol Infect Dis; 1995 Mar; 21(3):121-8. PubMed ID: 7648832
[TBL] [Abstract][Full Text] [Related]
20. Lyme disease: the evolution of erythema chronicum migrans into acrodermatitis chronica atrophicans.
Patmas MA
Cutis; 1993 Sep; 52(3):169-70. PubMed ID: 8243101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
